Medically reviewed by Daniel More, MD Many people with asthma as children go into long periods of remission, with infrequent ...

Dr. Neha Reshamwala, owner of Frontier Allergy, Asthma & Immunology, with BioBehavioral Research of Austin (BBRA) stopped by ...

The parents of a 22-year-old Wisconsin man who died after an asthma attack have filed a lawsuit against Walgreens and ...

Ethris announces promising phase 1 results for ETH47, its mRNA therapy for uncontrolled asthma. The inhaled treatment showed strong safety and efficacy, with plans for a phase 2 trial in 2025.

Severe thunderstorms are likely to produce heavy rainfall that may lead to flash flooding in the warning area over the next several hours. Locations which may be affected include Proserpine, Hamilton ...

A new treatment for severe dust mite allergy has been recommended by NICE, for patients whose symptoms have not been helped ...

Ethris GmbH, a leading biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced promising topline data from the completed Phase 1 clinical trial of its lead mRNA ...

Flu cases continue to rise across the region, and Augusta Health is offering some guidance on when to seek treatment.

Swiss pharma giant Roche Holding AG RHHBY posted better-than-expected 2024 results and provided an encouraging outlook for ...

Air pollution might protect against the most dangerous type of skin cancer, melanoma, a new study finds. However, it's ...

Over-exposure to an allergen also raises the risk of allergies, says David Cor ry, MD, professor of medicine in the section ...